Appointment of Philippe Dujardin to the Board of Directors
Chassieu (France), June 24, 2021 – 5:45 p.m. – AMOÉBA (FR0011051598 – ALMIB), producer of a biological biocide capable of eliminating bacterial risk in water and human wounds, and of a biocontrol product for plant protection, still in the development phase, announces the provisional appointment of Mr. Philippe Dujardin as an independent director of the Board of Directors, to replace Mr Pascal Reber for the remainder of his predecessor’s term of office, i.e. until the Ordinary General Meeting called to approve the financial statements for the year ending 31 December 2022, subject to ratification by the next Ordinary General Meeting.
After examining the situation of Mr Philippe Dujardin with regard to the independence criteria defined by the MiddleNext Code to which AMOEBA refers, the Board of Directors qualified Mr Philippe Dujardin as an independent director.
Philippe Dujardin has 30 years of experience in growth companies. Previously Deputy CEO of Awabot, Chief Financial Officer of Erytech Pharma, he was also Director of Financing and Investor Relations at Infogrames / Atari Group.
He joined BOOSTHEAT in 2014 as C.F.O and held the positions of Head of Development of BOOSTHEAT SA (partnerships, offers, international development…) and Chief Executive Officer of BOOSTHEAT France.
Philippe Dujardin is a graduate of the Ecole Supérieure de Commerce de Reims and of the Institut d’Etudes Politiques de Lyon.
Mr Pascal Reber will continue to bring his extensive experience and expertise to the service of the Company and will attend future meetings of the Board of Directors in a consultative role as censor.
“I welcome Philippe Dujardin to our Board of Directors. I am delighted with his arrival, which reinforces the good governance of the Company and complements the skills already present on the Board by bringing his solid financial expertise and his experience in the management of innovative companies. I would like to thank Pascal Reber for his support and involvement in the development of the company over the past 7 years”, says Fabrice Plasson, Chairman and CEO of Amoeba.